Trade-Ideas: McKesson (MCK) Is Today's New Lifetime High Stock

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified McKesson ( MCK) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified McKesson as such a stock due to the following factors:

  • MCK has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $137.7 million.
  • MCK has traded 2,500 shares today.
  • MCK is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in MCK with the Ticky from Trade-Ideas. See the FREE profile for MCK NOW at Trade-Ideas

More details on MCK:

McKesson Corporation delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The stock currently has a dividend yield of 0.5%. MCK has a PE ratio of 33.8. Currently there are 11 analysts that rate McKesson a buy, no analysts rate it a sell, and 2 rate it a hold.

The average volume for McKesson has been 1.0 million shares per day over the past 30 days. McKesson has a market cap of $45.2 billion and is part of the services sector and wholesale industry. The stock has a beta of 0.89 and a short float of 0.7% with 2.75 days to cover. Shares are up 20.8% year-to-date as of the close of trading on Friday.

If you liked this article you might like

How World's Largest Drug Distributor Is Helping Harvey Victims Treat Snakebites

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

Eclipse in the USA: Then and Now

Finding Value in a Pricey Environment

Allscripts Stock Climbs, Cantor Upgrades After McKesson Deal